Showing 1 - 10 results of 10 for search 'Thakurta, A', query time: 0.04s
Refine Results
-
1
Nanopore sequencing of single-cell transcriptomes with scCOLOR-seq by Philpott, M, Watson, J, Thakurta, A, Brown, T, Brown, T, Oppermann, U, Cribbs, AP
Published 2021Journal article -
2
Loss of COP9 signalosome gene-containing 2q region is associated with lenalidomide and pomalidomide resistance in myeloma patients by Gooding, S, Ansari-Pour, N, Kazeroun, MH, Karagoz, K, Salazar, MA, Fitzsimons, E, Estevez, MO, Towfic, F, Flynt, E, Pierceall, WE, Yong, K, Vyas, P, Thakurta, A
Published 2021Conference item -
3
Single Cell Analysis of Acquired Pomalidomide-Resistance in Multiple Myeloma Cell Lines Reveals Distinct Subclonal Cereblon Mutations and Gene Expression Heterogeneity by Gooding, S, Bjorklund, C, Amatangelo, M, Ren, Y, Marella, M, Couto, S, Park, C, Lata, S, Nibhani, R, Towfic, F, Oppermann, U, Ramasamy, K, Pierceall, W, Vyas, P, Thakurta, A
Published 2018Conference item -
4
Multiple cereblon genetic changes are associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma by Gooding, S, Ansari-Pour, N, Towfic, F, Ortiz Estévez, M, Chamberlain, PP, Tsai, K-T, Flynt, E, Hirst, M, Rozelle, D, Dhiman, P, Neri, P, Ramasamy, K, Bahlis, N, Vyas, P, Thakurta, A
Published 2020Journal article -
5
Repressed chromatin drives leukaemogenesis in mutant IDH2 acute myeloid leukaemia via inhibition of granulocyte differentiation and cell cycle progression by Silveira, DRA, Chatzikyriakou, P, Yavorska, O, Mackie, S, Hulks, R, Siejka-Zielinska, P, Corby, A, Smith, A, Brown, B, Metzner, M, Milne, TA, Penard-Lacronique, V, Song, C, Hasan, M, Thakurta, A, Vyas, P, Kriaucionis, S, Quek, L
Published 2021Conference item -
6
Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response by Amatangelo, MD, Quek, L, Shih, A, Stein, EM, Roshal, M, David, MD, Marteyn, B, Farnoud, NR, De Botton, S, Bernard, OA, Wu, B, Yen, KE, Tallman, MS, Papaemmanuil, E, Penard-Lacronique, V, Thakurta, A, Vyas, P, Levine, RL
Published 2017Journal article -
7
Loss Of COP9-signalosome genes Aa 2q37 is associated with IMiD agent resistance in multiple myeloma by Gooding, S, Ansari-Pour, N, Kazeroun, MH, Karagoz, K, Polonskaia, A, Angulo Salazar, M, Fitzsimons, E, Sirinukunwattana, K, Chavda, SJ, Ortiz Estevez, M, Towfic, F, Flynt, E, Pierceall, W, Royston, D, Yong, KL, Ramasamy, K, Vyas, P, Thakurta, A
Published 2022Journal article -
8
Clonal heterogeneity in differentiation response and resistance to the IDH2 inhibitor enasidenib in acute myeloid leukemia by Quek, L, David, M, Kennedy, A, Metzner, M, Amatangelo, M, Shih, A, Stoilova, B, Karamitros, D, Quivoron, C, Heiblig, M, Willekens, C, Saada, V, Peniket, A, Bernard, O, Agresta, S, Yen, K, Stein, E, De Botton, S, Thakurta, A, Levine, R, Penard-Lacronique, V, Vyas, P
Published 2017Conference item -
9
Clonal heterogeneity of acute Myeloid Leukemia treated with the IDH2 inhibitor Enasidenib by Vyas, P, Quek, L, David, MD, Kennedy, A, Metzner, M, Amatangelo, M, Shih, A, Stoilova, B, Quivoron, C, Heiblig, M, Willekens, C, Saada, V, Alsafadi, S, Vijayabaskar, MS, Peniket, A, Bernard, OA, Agresta, S, Yen, K, MacBeth, K, Stein, E, Vassiliou, GS, Levine, R, De Botton, S, Thakurta, A, Penard-Lacronique, V
Published 2018Journal article -
10
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma by Kurata, K, James-Bott, A, Tye, MA, Yamamoto, L, Samur, MK, Tai, Y-T, Dunford, J, Johansson, C, Senbabaoglu, F, Philpott, M, Palmer, C, Ramasamy, K, Gooding, S, Smilova, M, Gaeta, G, Guo, M, Christianson, JC, Payne, NC, Singh, K, Karagoz, K, Stokes, ME, Ortiz, M, Hagner, P, Thakurta, A, Cribbs, A, Mazitschek, R, Hideshima, T, Anderson, KC, Oppermann, U
Published 2023Journal article